GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $63.41 $75.66 Thursday, 18th Apr 2024 CYTK stock ended at $67.00. This is 1.37% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 2.53% from a day low at $66.84 to a day high of $68.53.
90 days $61.33 $84.92
52 weeks $25.98 $110.00

Historical Cytokinetics prices

Date Open High Low Close Volume
2020-09-18 $22.00 $22.00 $21.08 $21.81 3 291 072
2020-09-17 $21.72 $22.25 $21.49 $21.76 608 982
2020-09-16 $23.37 $23.50 $22.19 $22.28 596 851
2020-09-15 $23.38 $23.95 $22.84 $23.22 483 719
2020-09-14 $22.61 $23.57 $22.60 $23.00 1 020 714
2020-09-11 $23.06 $23.60 $22.42 $22.49 454 134
2020-09-10 $22.85 $23.34 $22.63 $22.79 644 071
2020-09-09 $22.68 $23.19 $22.55 $22.88 542 326
2020-09-08 $22.05 $23.24 $21.86 $22.50 466 620
2020-09-04 $23.24 $23.31 $21.25 $22.62 1 366 072
2020-09-03 $24.59 $25.09 $23.11 $23.17 744 001
2020-09-02 $24.19 $24.75 $23.88 $24.73 953 725
2020-09-01 $23.88 $24.24 $23.68 $24.14 627 468
2020-08-31 $24.22 $24.40 $23.85 $23.96 914 270
2020-08-28 $23.65 $24.95 $23.65 $24.33 1 280 401
2020-08-27 $24.20 $24.71 $23.09 $23.64 560 722
2020-08-26 $24.25 $24.62 $23.74 $23.93 790 798
2020-08-25 $23.18 $25.02 $22.81 $24.42 634 495
2020-08-24 $24.06 $24.60 $23.00 $23.16 682 590
2020-08-21 $25.00 $25.08 $23.45 $24.24 1 325 099
2020-08-20 $23.24 $24.29 $23.15 $24.21 1 049 705
2020-08-19 $23.97 $24.17 $23.26 $23.33 461 173
2020-08-18 $23.71 $24.15 $23.36 $24.12 542 715
2020-08-17 $22.63 $23.94 $22.50 $23.36 1 188 899
2020-08-14 $22.92 $22.92 $22.21 $22.52 553 264
Click to get the best stock tips daily for free!

About Cytokinetics

Cytokinetics Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in pati... CYTK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT